Syngenta Biosciences Profile
Key Indicators
- Authorised Capital ₹ 64.55 Cr
as on 23-10-2024
- Paid Up Capital ₹ 64.53 Cr
as on 23-10-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 18.58%
(FY 2023)
- Profit 27.96%
(FY 2023)
- Ebitda 13.43%
(FY 2023)
- Net Worth 6.98%
(FY 2023)
- Total Assets 6.54%
(FY 2023)
About Syngenta Biosciences
The Corporate was formerly known as Zeneca Biosciences Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 64.55 Cr and a paid-up capital of Rs 64.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Syngenta Biosciences Private Limited India is Rahul Sahu as COMPANY SECRETARY. Bhanumanjunath Narayan and Rajendra Hosmani serve as directors at the Company.
- CIN/LLPIN
U24210PN2001PTC135949
- Company No.
135949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Syngenta Biosciences Private Limited offer?
Syngenta Biosciences Private Limited offers a wide range of products and services, including Garden Plant, Lawn Grass, Fungicides, Plant Pots, Flower Pots, Herbicides, Organic Herbicides, Dry Leaves, Dried Flowers, Landscape Structure and Designing.
Who are the key members and board of directors at Syngenta Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Sahu | Company Secretary | 22-Jul-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhanumanjunath Narayan  | Whole-Time Director | 01-Apr-2012 | Current |
| Rajendra Hosmani | Whole-Time Director | 04-Dec-2018 | Current |
Financial Performance and Corporate Structure Insights of Syngenta Biosciences.
Syngenta Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.58% increase. The company also saw a substantial improvement in profitability, with a 27.96% increase in profit. The company's net worth moved up by a moderate rise of 6.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syngenta Biosciences?
In 2023, Syngenta Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syngenta Biosciences?
Syngenta Biosciences has a workforce of 216 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syngenta Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngenta Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
